Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine V Clark-Knowles

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathwayJohanne I Weberpals, Katherine V Clark-Knowles, Barbara C Vanderhyden
Journal of Oncology|February 26, 2010
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian CancerKatherine V Clark-Knowles, Anna M O'Brien, Johanne I Weberpals
Experimental Cell Research|October 31, 2006
Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changesKatherine V Clark-Knowles, Kenneth Garson, Jos Jonkers, et al.
Plos One|January 5, 2010
Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomasKatherine V Clark-Knowles, Mary K Senterman, Olga Collins, et al.
Genes & Cancer|September 11, 2013
SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological StressMichael W McBurney, Katherine V Clark-Knowles, Annabelle Z Caron, et al.
Plos One|November 27, 2013
SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancerKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|November 8, 2014
Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Cancer Cell International|August 23, 2011
The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cellsJohanne I Weberpals, Anna M O'Brien, Nima Niknejad, et al.
Experimental Cell Research|July 31, 2018
Modulating SIRT1 activity variously affects thymic lymphoma development in miceKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|March 9, 2017
Reversible modulation of SIRT1 activity in a mouse strainKatherine V Clark-Knowles, Xiaohong He, Karen Jardine, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathwayJohanne I Weberpals, Katherine V Clark-Knowles, Barbara C Vanderhyden
Journal of Oncology|February 26, 2010
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian CancerKatherine V Clark-Knowles, Anna M O'Brien, Johanne I Weberpals
Experimental Cell Research|October 31, 2006
Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changesKatherine V Clark-Knowles, Kenneth Garson, Jos Jonkers, et al.
Plos One|January 5, 2010
Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomasKatherine V Clark-Knowles, Mary K Senterman, Olga Collins, et al.
Genes & Cancer|September 11, 2013
SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological StressMichael W McBurney, Katherine V Clark-Knowles, Annabelle Z Caron, et al.
Plos One|November 27, 2013
SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancerKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|November 8, 2014
Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Cancer Cell International|August 23, 2011
The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cellsJohanne I Weberpals, Anna M O'Brien, Nima Niknejad, et al.
Experimental Cell Research|July 31, 2018
Modulating SIRT1 activity variously affects thymic lymphoma development in miceKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|March 9, 2017
Reversible modulation of SIRT1 activity in a mouse strainKatherine V Clark-Knowles, Xiaohong He, Karen Jardine, et al.
Pageof 1